Stéphane Nancey
Université Claude Bernard Lyon 1(FR)École Normale Supérieure de Lyon(FR)Centre National de la Recherche Scientifique(FR)Inserm(FR)Lyon College(US)Hospices Civils de Lyon(FR)Hospices Civils de Lyon(FR)Hôpital Lyon Sud(FR)Centre International de Recherche en Infectiologie(FR)HCL Technologies (India)(IN)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Microscopic Colitis, Immunodeficiency and Autoimmune Disorders, Eosinophilic Esophagitis, Diverticular Disease and Complications
Most-Cited Works
- → Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease(2016)338 cited
- → Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study(2017)321 cited
- → Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools(2017)225 cited
- → Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease(2016)190 cited
- → A Multicenter Experience With Infliximab for Ulcerative Colitis: Outcomes and Predictors of Response, Optimization, Colectomy, and Hospitalization(2010)179 cited
- → One‐year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study(2017)176 cited